Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002016-27Phase 2
Phase 2, open-label, single-arm trial of tapentadol in postoperative pain, sponsored by Grünenthal GmbH. Primary endpoint: Pharmacokinetic profile of tapentadol and tapentadol-O-glucuronide.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002016-27.